Company US Rare Earth Minerals Inc Other OTC
Equities
US9034101082
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
04-19 | Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Bioxytran, Inc. Announces Board Changes | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 18-02-28 |
Ola Soderquist
DFI | Director of Finance/CFO | 63 | - |
Leslie Ajayi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Sheikh
IRO | Public Communications Contact | 54 | 20-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Platt
CEO | Chief Executive Officer | 71 | 18-02-28 |
Dale Conaway
BRD | Director/Board Member | 69 | 18-11-01 |
Anders Utter
BRD | Director/Board Member | 57 | 18-11-01 |
Alan Hoberman
BRD | Director/Board Member | 71 | 18-11-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 174,962,481 | 75,447,287 ( 43.12 %) | 0 | 43.12 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- BIXT Stock
- Stock
- Company US Rare Earth Minerals Inc